| 0 (0%) | 09-27 14:24 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.58 | 1-year : | 7.21 |
| Resists | First : | 5.64 | Second : | 6.17 |
| Pivot price | 5.19  |
|||
| Supports | First : | 4.78 | Second : | 3.97 |
| MAs | MA(5) : | 5.01 |
MA(20) : | 5.32 |
| MA(100) : | 4.22 |
MA(250) : | 4.71 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 20.9 |
D(3) : | 21.3 |
| RSI | RSI(14): 43.9 |
|||
| 52-week | High : | 7.19 | Low : | 1.13 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ALDX ] has closed above bottom band by 39.4%. Bollinger Bands are 8.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.13 - 5.16 | 5.16 - 5.18 |
| Low: | 4.85 - 4.88 | 4.88 - 4.9 |
| Close: | 5.03 - 5.07 | 5.07 - 5.11 |
Sat, 27 Sep 2025
ALDX Stock Analysis and Forecast - Take Profit Strategies & Fast Growing Trading Ideas - Early Times
Wed, 24 Sep 2025
After Two Regulatory Setbacks For Reproxalap, Can Aldeyra's Persistence Pay Off? - RTTNews
Wed, 17 Sep 2025
Aldeyra: 2 CRLs And A Precedent Gap Ahead Of Repro's PDUFA Merit Caution (Rating Downgrade) - Seeking Alpha
Sat, 23 Aug 2025
JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9 - Yahoo Finance
Fri, 15 Aug 2025
Insider Purchase: Principal Financial Officer of $ALDX Buys 2,500 Shares | ALDX Stock News - Quiver Quantitative
Tue, 15 Jul 2025
Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 60 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 57.5 (%) |
| Shares Short | 5,290 (K) |
| Shares Short P.Month | 5,030 (K) |
| EPS | -0.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.92 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -31.6 % |
| Return on Equity (ttm) | -66 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.89 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -41 (M) |
| Levered Free Cash Flow | 18 (M) |
| PE Ratio | -5.97 |
| PEG Ratio | 0 |
| Price to Book value | 5.51 |
| Price to Sales | 0 |
| Price to Cash Flow | -7.42 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|